Investor

Mitsui Ventures

Last cheque observed Oct 2012. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series CSeries BSeries A

Cheques on record
0%of best year0cheques in 12 months, 45 on record
Since the last cheque5138days00hrs00min00sec
Median round$14MRounds led0 of 45Sole investor1 roundsExits12 from the portfolioMostly inUnited States, 90%
Pitch Mitsui Ventures

Mitsui Ventures highlights

  1. 01

    45 rounds on record

  2. 02

    Mostly Series C and Series B: 56% of its rounds

  3. 03

    Sole investor in 1 rounds, median $5.0M

  4. 04

    12 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first45 appearances

  1. 2012

    2 rounds

  2. Oct
    SopogySeries E · US · sec.gov$5.2MWith 3 others
  3. Jun
    General Mobile CorporationVenture · CN · finsmes.com$5.0MWith 2 others
  4. 2011

    4 rounds

  5. Dec
    GMZ EnergySeries C · US · venturebeat.com$14MWith 4 others
  6. Oct
    MoBeamSeries A · US · techcrunch.com$4.9MWith 2 others
  7. Jun
    ProterraSeries A · US · techcrunch.com$30MWith 6 others
  8. May
    BioAmberSeries B · US · finance.yahoo.com$45MWith 1 other
  9. 2010

    6 rounds

  10. Oct
    Cappella Medical DevicesSeries D · IE · finsmes.com$15MWith 4 others
  11. Sept
    SenSageVenture · US · sensage.com$6.3MWith 4 others
  12. Sept
    S*BioGrowth · SG · sbio.com$5.0MSole investor
  13. Feb
    LensVectorSeries C · US · lensvector.com$30MWith 7 others
  14. Jan
    Laszlo SystemsVenture · US · deals.venturebeat.com$3.0MWith 3 others
  15. Jan
    DNP Green TechnologySeries A · US · onbiovc.com$12MWith 5 others
  16. 2009

    4 rounds

  17. Dec
    SolariaDebt · US · deals.venturebeat.com$7.0MWith 6 others
  18. Jul
    KovioSeries E · US · deals.venturebeat.com$20MWith 10 others
  19. Apr
    CellBiosciencesSeries C · US · pehub.com$10MWith 6 others
  20. Jan
    Axikin PharmaceuticalsSeries A · US · reuters.com$3.0MWith 1 other
  21. 2008

    6 rounds

  22. Oct
    Biolex TherapeuticsSeries D · US · mitsuiventures.com$60MWith 10 others
  23. Jul
    A10 NetworksSeries C · US · a10networks.com$23MWith 3 others
  24. May
    PalamidaSeries C · US · sec.gov$5.5MWith 2 others
  25. Apr
    SenSageVenture · US · venturebeat.com$15MWith 4 others
  26. Mar
    Laszlo SystemsSeries C · US · techcrunch.com$15MWith 3 others
  27. Jan
    NanoGramSeries C · US · nanogram.com$32MWith 13 others
  28. 2007

    5 rounds

  29. Sept
    StartForceSeries A · US$1.0MWith 1 other
  30. May
    Biolex TherapeuticsSeries C · US · biolex.com$30MWith 8 others
  31. Apr
    DiObexSeries B · US · deals.venturebeat.com$24MWith 5 others
  32. Apr
    SenSageSeries D · US · venturedeal.com$5.0MWith 3 others
  33. Feb
    Beceem CommunicationsSeries D · US · beceem.com$40MWith 10 others
  34. 2006

    11 rounds

  35. Oct
    SynacorSeries C · US · synacor.com$17MWith 6 others
  36. Aug
    Efficient FrontierSeries C · US · deals.venturebeat.com$6.0MWith 2 others
  37. Aug
    Boingo WirelessSeries C · US · lightreading.com$65MWith 2 others
  38. Jul
    AelurosVenture · US$8.0MWith 3 others
  39. Jun
    RGB NetworksSeries C · US · dmwmedia.com$20MWith 4 others
  40. Jun
    PalamidaSeries B · US · news.cnet.com$8.0MWith 2 others
  41. Jun
    InnoPath SoftwareSeries D · US$21MWith 2 others
  42. Jun
    NanosolarSeries C · US · electroiq.com$75MWith 12 others
  43. Mar
    GalazarSeries C · CA · opticalkeyhole.com$6.6MWith 7 others
  44. Mar
    EKOS CorporationSeries C · US · ekoscorp.com$26MWith 8 others
  45. Jan
    CellBiosciencesSeries B · US · bio-medicine.org$27MWith 7 others
  46. 2005

    7 rounds

  47. Sept
    Biolex TherapeuticsSeries B · US · biolex.com$36MWith 5 others
  48. May
    NanosolarSeries B · US · nanosolar.com$20MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed12 in all

CellBiosciencesBought by Bio-TechneUndisclosedJun 2014
KovioBought by Thin Film Electronics ASA$3.7MJan 2014
EKOS CorporationBought by BTG$220MMay 2013
BioAmberListed$80MMay 2013
Laszlo SystemsBought by Critical Path Inc.UndisclosedFeb 2012
AelurosBought by Broadcom$3.7BFeb 2012
Efficient FrontierBought by Adobe Systems$400MNov 2011
StartForceBought by ZeroDesktopUndisclosedFeb 2011
Beceem CommunicationsBought by Broadcom$316MOct 2010
NanoGramBought by Teijin LimitedUndisclosedJul 2010
GalazarBought by EXARUndisclosedJun 2009

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Mitsui Ventures. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Mitsui Ventures

What does Mitsui Ventures invest in?

Mitsui Ventures invests most often at Series C and Series B (56% of the rounds on record).

How active is Mitsui Ventures?

45 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2012.

How big are Mitsui Ventures's cheques?

The median round it joins is $14M.

Does Mitsui Ventures lead rounds?

Rarely, if at all: none of its 45 investments on record names it as the lead.

Where does Mitsui Ventures invest?

Most of the companies it backs are in the United States (90%).

Is Mitsui Ventures investing now?

No investments in the last 12 months; the latest was in Oct 2012.

Who does Mitsui Ventures invest alongside?

Most often Kleiner Perkins Caufield & Byers (5 rounds together), Canaan (4 rounds together) and Samsung Venture Investment (4 rounds together).

What kind of investor is Mitsui Ventures?

Mitsui Ventures is a growth equity firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it